CN101057890A - 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 - Google Patents
一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 Download PDFInfo
- Publication number
- CN101057890A CN101057890A CN 200610076302 CN200610076302A CN101057890A CN 101057890 A CN101057890 A CN 101057890A CN 200610076302 CN200610076302 CN 200610076302 CN 200610076302 A CN200610076302 A CN 200610076302A CN 101057890 A CN101057890 A CN 101057890A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- rhizoma corydalis
- medicine composition
- heart disease
- total alkaloids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 19
- 229930013930 alkaloid Natural products 0.000 claims abstract description 82
- 239000003814 drug Substances 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 17
- 241000218176 Corydalis Species 0.000 claims description 99
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 66
- 239000011347 resin Substances 0.000 claims description 42
- 229920005989 resin Polymers 0.000 claims description 42
- 239000000243 solution Substances 0.000 claims description 30
- 238000010828 elution Methods 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 12
- 239000007924 injection Substances 0.000 claims description 12
- 238000002347 injection Methods 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 238000005325 percolation Methods 0.000 claims description 7
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000000638 solvent extraction Methods 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 235000006961 Fumaria officinalis Nutrition 0.000 claims description 2
- 241001457306 Fumaria officinalis subsp. officinalis Species 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 238000005341 cation exchange Methods 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 235000010265 sodium sulphite Nutrition 0.000 claims description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 239000001117 sulphuric acid Substances 0.000 claims description 2
- 235000011149 sulphuric acid Nutrition 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract description 16
- 230000008569 process Effects 0.000 abstract description 3
- 241000620709 Corydalis ambigua Species 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 14
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 9
- 239000013558 reference substance Substances 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000012567 medical material Substances 0.000 description 7
- 239000003513 alkali Substances 0.000 description 6
- 208000031225 myocardial ischemia Diseases 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- GVZVHYFESLXAML-YRNVUSSQSA-N 3-[2-(dimethylamino)ethyl]-6-methoxy-2-[(E)-2-(4-methoxyphenyl)ethenyl]phenol Chemical compound O(C)c1c(O)c(/C=C/c2ccc(OC)cc2)c(CCN(C)C)cc1 GVZVHYFESLXAML-YRNVUSSQSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000000274 adsorptive effect Effects 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- HYBRYAPKQCZIAE-UHFFFAOYSA-N allocryptopine Chemical compound C1=C2CCN(C)CC3=C(OC)C(OC)=CC=C3CC(=O)C2=CC2=C1OCO2 HYBRYAPKQCZIAE-UHFFFAOYSA-N 0.000 description 3
- NGFLTEGALWMQIJ-UHFFFAOYSA-N allocryptopine Natural products COc1ccc2CC(=O)c3cc4OCOc4cc3CN(C)CCc2c1OC NGFLTEGALWMQIJ-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- DIHXHTWYVOYYDC-INIZCTEOSA-N (13as)-2,3,9-trimethoxy-6,8,13,13a-tetrahydro-5h-isoquinolino[2,1-b]isoquinolin-10-ol Chemical compound C1CN2CC(C(=C(O)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 DIHXHTWYVOYYDC-INIZCTEOSA-N 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 2
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 2
- 241000830532 Corydalis yanhusuo Species 0.000 description 2
- RFKQJTRWODZPHF-UHFFFAOYSA-N Dehydrocorydaline Natural products COC1=C(OC)C=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C(C)=C3C2=C1 RFKQJTRWODZPHF-UHFFFAOYSA-N 0.000 description 2
- VQSYXVWEZATIHL-UHFFFAOYSA-O Dehydrocorydalmine Chemical compound OC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC VQSYXVWEZATIHL-UHFFFAOYSA-O 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 2
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 2
- -1 alkaloid compound Chemical class 0.000 description 2
- HUIJAZQRYSCNED-UHFFFAOYSA-N alpha-allo-cryptopine Natural products C1CN(C)CC2=C(OC)C(OC)=CC=C2CC(=O)C2=CC(OC)=C(OC)C=C21 HUIJAZQRYSCNED-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- XYHOBCMEDLZUMP-UHFFFAOYSA-N coptisine Chemical compound C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 XYHOBCMEDLZUMP-UHFFFAOYSA-N 0.000 description 2
- HKIDROLXYXYQOZ-UHFFFAOYSA-N dehydrocorydaline Chemical compound C1C2=C(OC)C(OC)=CC=C2C(C)=C2N1CCC1=C2C=C(OC)C(OC)=C1 HKIDROLXYXYQOZ-UHFFFAOYSA-N 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- CHWPMFMUQATVNK-ARYYTZDLSA-N dihydrosporogen AO-1 Natural products O[C@H]1[C@]2(C(C)=C)O[C@@H]2[C@]2(C)[C@@H](C)[C@H](O)CCC2=C1 CHWPMFMUQATVNK-ARYYTZDLSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- UKIOTQZYKUPESG-UHFFFAOYSA-N dl-Tetrahydrocoptisine Natural products C1=C2C(C)C3C4=CC(OCO5)=C5C=C4CCN3CC2=C2OCOC2=C1 UKIOTQZYKUPESG-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010812 external standard method Methods 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- OBVLTWCOTSTMNM-FKIZINRSSA-N (13s,13ar)-2,9,10-trimethoxy-13-methyl-6,8,13,13a-tetrahydro-5h-isoquinolino[2,1-b]isoquinolin-3-ol Chemical compound C1([C@@H]2C)=CC=C(OC)C(OC)=C1CN1[C@H]2C(C=C(C(=C2)O)OC)=C2CC1 OBVLTWCOTSTMNM-FKIZINRSSA-N 0.000 description 1
- KDFKJOFJHSVROC-INIZCTEOSA-N (S)-tetrahydrocolumbamine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(O)=C2 KDFKJOFJHSVROC-INIZCTEOSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical group C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- ZUAPXIXLBSQDNW-UHFFFAOYSA-N Dihydroavicine Natural products Cc1cc2OCOc2c3CNc4c(ccc5cc6OCOc6cc45)c13 ZUAPXIXLBSQDNW-UHFFFAOYSA-N 0.000 description 1
- VXPARNCTMSWSHF-DNVSUFBTSA-N Dihydrosanguinarine Natural products O=C1[C@H](C(C)=C)C[C@]2(CO)[C@@H](C)[C@H](O)CCC2=C1 VXPARNCTMSWSHF-DNVSUFBTSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- OBVLTWCOTSTMNM-UHFFFAOYSA-N Tetrahydrocorybulbin Natural products CC1C2=CC=C(OC)C(OC)=C2CN2C1C(C=C(C(=C1)O)OC)=C1CC2 OBVLTWCOTSTMNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- YYFOFDHQVIODOQ-UHFFFAOYSA-O columbamine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)O)OC)CC3)[N+]3=CC2=C1OC YYFOFDHQVIODOQ-UHFFFAOYSA-O 0.000 description 1
- CYOURJWVXZHEPP-UHFFFAOYSA-N columbamine Natural products COc1cc2CCN3Cc4c(OC)c(OC)ccc4C=C3c2cc1O CYOURJWVXZHEPP-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- CIUHLXZTZWTVFL-UHFFFAOYSA-N dihydrosanguinarine Chemical compound C1=C2OCOC2=CC2=C3N(C)CC4=C(OCO5)C5=CC=C4C3=CC=C21 CIUHLXZTZWTVFL-UHFFFAOYSA-N 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
- 229940012189 methyl orange Drugs 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- DIHXHTWYVOYYDC-UHFFFAOYSA-N tetrahydropalmatin Natural products C1CN2CC(C(=C(O)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 DIHXHTWYVOYYDC-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 剂量mg/kg | 造模后各时间点T波变化(mv) | |||||
15s | 30s | 1min | 5min | 10min | 15min | ||
正常组模型组阳性组5mg/kg15mg/kg45mg/kg135mg/kg | 2551545135 | 0.017±0.0130.123±0.054#0.037±0.040*0.028±0.012*0.046±0.030*0.010±0.006*0.020±0.014* | 0.014±0.0060.117±0.040#0.038±0.011**0.078±0.0460.037±0.029*0.045±0.025*0.066±0.019* | 0.012±0.0100.081±0.032#0.070±0.0240.069±0.0300.044±0.030*0.044±0.030*0.041±0.037* | 0.01±0..0110.059±0.0370.036±0.0230.058±0.0240.038±0.0250.016±0.0050.024±0.015 | 0.014±0.0080.043±0.0540.023±0.0100.063±0.0660.027±0.0160.035±0.0480.052±0.055 | 0.014±0.0080.033±0.0360.030±0..0200.031±0.0270.020±0.0200.019±0.0200.033±0.028 |
组别 | 剂量mg/kg | 造模后各时间点心率变化 | |||||
15s | 30s | 60s | 5min | 10min | 15min | ||
正常组模型组阳性组5mg/kg15mg/kg45mg/kg135mg/kg | 2551545135 | 8.11±4.9039.4±37.985.5±92.432.0±20.443.3±28.427.1±26.237.1±13.3 | 4.65±3.7944.2±33.570.4±43.454.3±29.760.0±55.524.3±25.744.1±17.1 | 10.0±2.7661.9±31.2#69.5±38.073.0±39.955.6±48.424.9±26.262.3±32.1 | 17.8±12.470.2±59.888.9±62.3111.9±21.588.7±29.367.1±7.6695.3±27.4 | 29.0±17.765.8±52.497.6±48.8109.9±6.0488.2±36.177.5±19.199.7±34.4 | 45.0±9.3685.1±45.694.0±36.9115.3±9.3589.5±32.882.8±18.2103.5±37.8 |
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100763022A CN101057890B (zh) | 2006-04-20 | 2006-04-20 | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100763022A CN101057890B (zh) | 2006-04-20 | 2006-04-20 | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101057890A true CN101057890A (zh) | 2007-10-24 |
CN101057890B CN101057890B (zh) | 2011-07-20 |
Family
ID=38864293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100763022A Expired - Fee Related CN101057890B (zh) | 2006-04-20 | 2006-04-20 | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101057890B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101435812A (zh) * | 2008-12-15 | 2009-05-20 | 青岛华仁太医药业有限公司 | 蒲元和胃胶囊质量标准检测方法 |
CN101284050B (zh) * | 2008-05-09 | 2011-02-16 | 浙江现代中药与天然药物研究院有限公司 | 延胡索水溶性部位药物及制备方法和用途 |
CN101406527B (zh) * | 2008-11-27 | 2011-12-07 | 黑龙江中医药大学 | 延胡索总生物碱盐的制备方法及其作为治疗心血管疾病药物的应用 |
EP2679233A1 (en) * | 2012-06-25 | 2014-01-01 | Heshengyuan of Chinese Medicine Research & Development Company Limited in Shunde District of Foshan | A preparation used for anti-tachyarrhythmia and its preparation method |
CN107281274A (zh) * | 2017-06-08 | 2017-10-24 | 张挺 | 一种含元胡的中药粉针剂 |
CN116139199A (zh) * | 2023-01-18 | 2023-05-23 | 昆明市宇斯药业有限责任公司 | 一种雪上一枝蒿总生物碱组合物及其制备方法 |
CN116139197A (zh) * | 2023-03-01 | 2023-05-23 | 岭南中药饮片有限公司 | 一种醋延胡索配方颗粒制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1241923C (zh) * | 2002-03-20 | 2006-02-15 | 江西天施康中药股份有限公司 | 夏天无总生物碱的提取方法及其新的用途 |
CN100387250C (zh) * | 2005-08-12 | 2008-05-14 | 北京科信必成医药科技发展有限公司 | 延胡索滴丸 |
-
2006
- 2006-04-20 CN CN2006100763022A patent/CN101057890B/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284050B (zh) * | 2008-05-09 | 2011-02-16 | 浙江现代中药与天然药物研究院有限公司 | 延胡索水溶性部位药物及制备方法和用途 |
CN101406527B (zh) * | 2008-11-27 | 2011-12-07 | 黑龙江中医药大学 | 延胡索总生物碱盐的制备方法及其作为治疗心血管疾病药物的应用 |
CN101435812A (zh) * | 2008-12-15 | 2009-05-20 | 青岛华仁太医药业有限公司 | 蒲元和胃胶囊质量标准检测方法 |
EP2679233A1 (en) * | 2012-06-25 | 2014-01-01 | Heshengyuan of Chinese Medicine Research & Development Company Limited in Shunde District of Foshan | A preparation used for anti-tachyarrhythmia and its preparation method |
CN107281274A (zh) * | 2017-06-08 | 2017-10-24 | 张挺 | 一种含元胡的中药粉针剂 |
CN116139199A (zh) * | 2023-01-18 | 2023-05-23 | 昆明市宇斯药业有限责任公司 | 一种雪上一枝蒿总生物碱组合物及其制备方法 |
CN116139197A (zh) * | 2023-03-01 | 2023-05-23 | 岭南中药饮片有限公司 | 一种醋延胡索配方颗粒制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101057890B (zh) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101554409B (zh) | 荜茇生物碱及其制备方法、制剂和用途 | |
CN101057890B (zh) | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 | |
US9687516B2 (en) | Preparation method for extractive of jinxuan hemorrhoid washing powder botanicals | |
CN103977179B (zh) | 一种具有抗痴呆作用的药物物质及其制备方法与应用 | |
CN1872106A (zh) | 山香圆叶在治疗病毒性感冒疾病中的应用 | |
CN101396384A (zh) | 一种积雪草提取物及其制备方法 | |
CN102240322B (zh) | 一种复方丹参片及其制备工艺 | |
CN103893258A (zh) | 含有广金钱草总黄酮的口服固体制剂及其应用 | |
CN103340983A (zh) | 黑果枸杞果实提取物及制备方法和应用 | |
CN102397342A (zh) | 一种金荞麦提取物,含其制剂及其制备方法 | |
CN101164566B (zh) | 一种牡丹叶总苷提取物及其制备方法和用途 | |
CN1709417A (zh) | 一种杏香兔耳风提取物及其制备方法 | |
CN1660380A (zh) | 良附滴丸的制备方法及质量控制方法 | |
CN101601700A (zh) | 黑水缬草有效部位提取物及其质量控制方法和医药用途 | |
CN101204429B (zh) | 一种牡丹叶总黄酮提取物及其制备方法和用途 | |
CN1772084A (zh) | 一种通舒口爽片及其制备方法 | |
CN100536868C (zh) | 高含量丹参多酚酸盐粉针剂及其制备方法 | |
CN1879850A (zh) | 仙蟾胶囊及其制备方法、质量控制方法 | |
WO2014000119A1 (zh) | 一种抗快速性心律失常的制剂及其制备方法 | |
CN1857385B (zh) | 一种治疗颈椎病的药物组合物及其制备方法 | |
CN101642492B (zh) | 治疗慢性盆腔炎的药物及其制备方法 | |
CN102885985A (zh) | 天麻川芎复方提取物的制备方法及应用 | |
CN100584345C (zh) | 具抗病毒作用的小紫金牛提取物及其提取方法和应用 | |
CN1264506C (zh) | 一种丹参素的药物组合物的制备方法 | |
CN101077364A (zh) | 一种治疗心脑血管病的中药组合物及其制剂和制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIDA SHIJIA TECHNOLOGY DEVELOPMENT CO., LTD. Free format text: FORMER OWNER: ZHOU YAWEI Effective date: 20150119 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150119 Address after: 100084 No. 123 North Main Street, Haidian District, Beijing, Zhongguancun Patentee after: Beida Shijia Technology Development Co. Ltd. Address before: 100084, Beijing, Zhongguancun, Haidian District North 123 Avenue, branch office incubator room 2206 Patentee before: Zhou Yawei |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 102206, 20 floor, No. 6, life road, Beijing, Changping District, 3 Patentee after: Beida Shijia Technology Development Co. Ltd. Address before: 100084 No. 123 North Main Street, Haidian District, Beijing, Zhongguancun Patentee before: Beida Shijia Technology Development Co. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20210420 |
|
CF01 | Termination of patent right due to non-payment of annual fee |